49 results
424B3
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement
4:53pm
pathways, which are involved in protecting cells from oxidative stress that can lead to cell death.
AJ201 is currently being studied in a Phase 1b/2a … increase in the authorized number of directors or the death, resignation, retirement, disqualification, removal from office or other cause
424B5
ATXI
Avenue Therapeutics Inc
10 May 24
Prospectus supplement for primary offering
4:52pm
are involved in protecting cells from oxidative stress that can lead to cell death. AJ201 is currently being studied in a Phase 1b/2a multicenter
424B3
ATXI
Avenue Therapeutics Inc
2 Feb 24
Prospectus supplement
12:00am
in the authorized number of directors or the death, resignation, retirement, disqualification, removal from office or other cause will be filled by a majority
424B4
xqsft5n01i0jo
2 Nov 23
Prospectus supplement with pricing info
9:00am
FWP
34m2u5a cj
5 Oct 23
Free writing prospectus
5:05pm
FWP
053xylxe e80
3 Oct 23
Free writing prospectus
5:47pm
8-K
EX-10.1
r5ft15ti402673 sov
5 Jul 23
Departure of Directors or Certain Officers
4:15pm
424B3
wavd521xxxxb
28 Jun 23
Prospectus supplement
4:56pm
424B3
orf8q3tt
4 May 23
Prospectus supplement
4:30pm